Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Gastroenterology|October 13, 2006
APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progressionKlaus-Peter Janssen, Paola Alberici, Hafida Fsihi, et al.Genes, Chromosomes & Cancer|August 31, 2002
A 10-Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North-American kindredAnja Wagner, Heleen van der Klift, Patrick Franken, et al.Genesis (New York, N.Y. : 2000)|September 7, 2017
Axin2-mTurquoise2: A novel reporter mouse model for the detection of canonical Wnt signallingJolanda J D de Roo, Cor Breukel, Amiet R Chhatta, et al.Carcinogenesis|February 24, 2010
A new conditional Apc-mutant mouse model for colorectal cancerEls C Robanus-Maandag, Pim J Koelink, Cor Breukel, et al.Oncotarget|July 24, 2018
FcγRI expression on macrophages is required for antibody-mediated tumor protection by cytomegalovirus-based vaccinesHreinn Benonisson, Heng Sheng Sow, Cor Breukel, et al.Molecular Therapy. Nucleic Acids|January 24, 2013
Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP)A Seda Yılmaz-Eliş, Annemieke Aartsma-Rus, Peter Ac 't Hoen, et al.Plos One|February 22, 2018
A dystrophic Duchenne mouse model for testing human antisense oligonucleotidesMarcel Veltrop, Laura van Vliet, Margriet Hulsker, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2014
FcγRIIb on myeloid cells rather than on B cells protects from collagen-induced arthritisA Seda Yilmaz-Elis, Javier Martin Ramirez, Patrick Asmawidjaja, et al.Science Advances|February 9, 2024
CDCA7-associated global aberrant DNA hypomethylation translates to localized, tissue-specific transcriptional responsesMaja Vukic, Jihed Chouaref, Veronica Della Chiara, et al.International Journal of Cancer|September 28, 2018
FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor modelHeng Sheng Sow, Hreinn Benonisson, Cor Breukel, et al.Pageof 3